How is Lutetium Lu 177 Dotatate (Intravenous Route) dosed?
The dosage form of Lutetium Lu 177 dotatate is a solution. The dosage and administration of this medicine should be done under the direct supervision of a doctor with specialized training in nuclear medicine. Please consult your doctor or healthcare professional for the appropriate dosing information based on your medical condition, age, and other factors.
What is the dosage form of Lutetium Lu 177 Dotatate (Intravenous Route)?
The dosage form of Lutetium Lu 177 Dotatate intravenous route is Solution.
What medications are contraindication with Lutetium Lu 177 Dotatate (Intravenous Route)?
Medications that may interact with lutetium Lu 177 dotatate include amino acid solutions containing high levels of arginine or lysine, anticoagulants (blood thinners) like warfarin, calcium channel blockers like verapamil or diltiazem, diuretics like furosemide or hydrochlorothiazide, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or aspirin, and other medications that may affect kidney function. It is important to inform your doctor about all the medications you are taking, as they may need to adjust the dosages or monitor you more closely during your treatment. Please consult your healthcare professional for specific advice regarding your medical history and current medications.
How is Lutetium Lu 177 Dotatate (Intravenous Route) administered?
Lutetium Lu 177 dotatate intravenous route is administered by a healthcare professional in a hospital or cancer treatment center. The medicine is given through a needle placed into one of the patient's veins. Before the administration, the patient receives medicines to prevent nausea and vomiting 30 minutes before receiving the amino acid solution. The amino acid solution is given 30 minutes before, during, and for at least 3 hours after receiving the medicine.
What are common precautions when taking Lutetium Lu 177 Dotatate (Intravenous Route)?
Common precautions when taking lutetium Lu 177 dotatate intravenously include:
- Kidney disease: Lutetium Lu 177 dotatate may lower the number of some types of blood cells in your body, which could increase the risk of bleeding or infections. Inform your doctor if you have kidney disease, mild to moderate or severe.
- Liver disease: The medication has not been studied in patients with severe liver disease, so consult your doctor if you have liver disease.
- Proper use: Understand the risks and benefits of the medication and work closely with your doctor during treatment.
- Preventing nausea: Receive medicines to prevent nausea and vomiting 30 minutes before receiving the amino acid solution.
- Amino acid solution: Receive the amino acid solution 30 minutes before, during, and for at least 3 hours after receiving the medication.
- Blood cell count: Be aware that the medication may lower the number of some types of blood cells in your body, which could lead to bleeding or infections.
- Infections: Avoid being near people who are sick or have infections. Wash your hands often, stay away from rough sports or situations where you could be bruised or injured, brush and floss your teeth gently, and be careful when using sharp objects.
- Serious kidney problems: Watch for symptoms such as bloody urine, decreased urine frequency or amount, increased blood pressure, increased thirst, loss of appetite, lower back or side pain, nausea, swelling of the face, fingers, or lower legs, troubled breathing, unusual tiredness or weakness, vomiting, or weight gain. Drink plenty of fluids and urinate as often as possible during and after receiving the medication.
Please consult your doctor or healthcare professional for specific advice on precautions and instructions related to your individual circumstances.